Dogwood Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 13
Rang # Quantité totale PI 118 006
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 675 527
Symbole boursier DWTX (nasdaq)

Brevets

Marques

13 0
0 0
0 0
0
 
Dernier brevet 2018 - Synergistic famciclovir and cele...
Premier brevet 2013 - Antiviral compound and cox-2 inh...

Derniers inventions, produits et services

2017 Invention Synergistic famciclovir and celecoxib combination therapy for functional somatic syndromes. The p...
Invention Famciclovir and celecoxib combination therapy for functional somatic syndromes. The present inven...
2015 Invention Valaciclovir and meloxicam combination therapy for functional somatic syndromes. The present inve...
2014 Invention Method to treat functional somatic syndromes with combination of aciclovir and celecoxib. The pre...
Invention Acyclovir and meloxicam combination therapy for functional somatic syndromes. The present inventi...
Invention Valaciclovir and celecoxib combination for functional somatic syndromes. The present invention re...
Invention Method of treating functional somatic syndromes with combination of famciclovir and celecoxib. Th...
2013 Invention Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, incl...
Invention Famciclovir and meloxicam combination therapy for functional somatic syndromes. The present inven...
Invention Valaciclovir and diclofenac combination therapy for functional somatic syndromes. The present inv...
Invention Method of treating functional somatic syndromes with combination of famciclovir and diclofenac. T...
Invention Aciclovir and diclofenac combination therapy for functional somatic syndromes. The present invent...